AbbVie has discontinued an ongoing phase 3 trial evaluating its antibody drug conjugate (ADC) depatuxizumab mafodotin (Depatux-M) for the treatment of newly diagnosed glioblastoma (GBM), an aggressive type of brain cancer, owing to futility. The […]
SMi reports: With only two weeks until SMi’s 3rd Annual Pharmaceutical Microbiology West Coast taking place in San Diegoon June 5th& 6th 2019, the event has sold out! Rapid microbiological testing is gaining momentum in […]
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline plc […]
WuXi Biologics, a global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has entered into a strategic partnership letter of intent (LOI) with a global vaccine […]
Merck has signed an agreement to acquire Peloton Therapeutics, a US-based clinical-stage biopharmaceutical firm, in a deal valued at around $2.2bn (£1.72bn). Under the deal, Merck’s subsidiary will purchase all outstanding shares of Peloton in […]